United Kingdom (UK) Clinical Oncology NGS Market (2025-2031) | Outlook, Companies, Share, Segmentation, Industry, Forecast, Growth, Value, Trends, Size & Revenue, Analysis, Competitive Landscape

Market Forecast By Technology (Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing Centrifuges), By Workflow (Pre-Sequencing, Sequencing, Data Analysis), By Application (Screening, Companion Diagnostics, Other Diagnostics), By End-use (Hospitals, Clinics, Laboratories) And Competitive Landscape
Product Code: ETC9940947 Publication Date: Sep 2024 Updated Date: Jan 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United Kingdom (UK) Clinical Oncology NGS Market Outlook
  • Market Size of United Kingdom (UK) Clinical Oncology NGS Market, 2024
  • Forecast of United Kingdom (UK) Clinical Oncology NGS Market, 2031
  • Historical Data and Forecast of United Kingdom (UK) Clinical Oncology NGS Revenues & Volume for the Period 2021- 2031
  • United Kingdom (UK) Clinical Oncology NGS Market Trend Evolution
  • United Kingdom (UK) Clinical Oncology NGS Market Drivers and Challenges
  • United Kingdom (UK) Clinical Oncology NGS Price Trends
  • United Kingdom (UK) Clinical Oncology NGS Porter's Five Forces
  • United Kingdom (UK) Clinical Oncology NGS Industry Life Cycle
  • Historical Data and Forecast of United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume By Technology for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume By Whole Genome Sequencing for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume By Whole Exome Sequencing for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume By Targeted Sequencing & Resequencing Centrifuges for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume By Workflow for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume By Pre-Sequencing for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume By Sequencing for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume By Data Analysis for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume By Screening for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume By Companion Diagnostics for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume By Other Diagnostics for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume By End-use for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume By Clinics for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume By Laboratories for the Period 2021- 2031
  • United Kingdom (UK) Clinical Oncology NGS Import Export Trade Statistics
  • Market Opportunity Assessment By Technology
  • Market Opportunity Assessment By Workflow
  • Market Opportunity Assessment By Application
  • Market Opportunity Assessment By End-use
  • United Kingdom (UK) Clinical Oncology NGS Top Companies Market Share
  • United Kingdom (UK) Clinical Oncology NGS Competitive Benchmarking By Technical and Operational Parameters
  • United Kingdom (UK) Clinical Oncology NGS Company Profiles
  • United Kingdom (UK) Clinical Oncology NGS Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United Kingdom (UK) Clinical Oncology NGS Market Overview

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Clinical Oncology NGS Market - Industry Life Cycle

3.4 United Kingdom (UK) Clinical Oncology NGS Market - Porter's Five Forces

3.5 United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F

3.7 United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F

3.8 United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F

4 United Kingdom (UK) Clinical Oncology NGS Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 United Kingdom (UK) Clinical Oncology NGS Market Trends

6 United Kingdom (UK) Clinical Oncology NGS Market, By Types

6.1 United Kingdom (UK) Clinical Oncology NGS Market, By Technology

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F

6.1.4 United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F

6.1.5 United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume, By Targeted Sequencing & Resequencing Centrifuges, 2021- 2031F

6.2 United Kingdom (UK) Clinical Oncology NGS Market, By Workflow

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F

6.2.3 United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F

6.2.4 United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume, By Data Analysis, 2021- 2031F

6.3 United Kingdom (UK) Clinical Oncology NGS Market, By Application

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume, By Screening, 2021- 2031F

6.3.3 United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F

6.3.4 United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume, By Other Diagnostics, 2021- 2031F

6.4 United Kingdom (UK) Clinical Oncology NGS Market, By End-use

6.4.1 Overview and Analysis

6.4.2 United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 United Kingdom (UK) Clinical Oncology NGS Market Revenues & Volume, By Laboratories, 2021- 2031F

7 United Kingdom (UK) Clinical Oncology NGS Market Import-Export Trade Statistics

7.1 United Kingdom (UK) Clinical Oncology NGS Market Export to Major Countries

7.2 United Kingdom (UK) Clinical Oncology NGS Market Imports from Major Countries

8 United Kingdom (UK) Clinical Oncology NGS Market Key Performance Indicators

9 United Kingdom (UK) Clinical Oncology NGS Market - Opportunity Assessment

9.1 United Kingdom (UK) Clinical Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 United Kingdom (UK) Clinical Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F

9.3 United Kingdom (UK) Clinical Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F

9.4 United Kingdom (UK) Clinical Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F

10 United Kingdom (UK) Clinical Oncology NGS Market - Competitive Landscape

10.1 United Kingdom (UK) Clinical Oncology NGS Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Clinical Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All